ArticleOncotarget2018

CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator.

Yong Wha Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.